Sterne, Kessler, Goldstein & Fox P.L.L.C. (JD Supra Taiwan)

In December 2017, the Taiwan Pharmaceutical Affairs Act has been amended to harmonize generic approval process with prevailing international norms. The amended Act is expected to come into effect in late 2018 or early 2019. As discussed below, the amendment (1) introduces data exclusivity periods for new chemical entities and new/changed indications of previously approved drugs, and (2)...

Patent protection in Taiwan has increased in importance as the economic relationship between the US, Europe, and Taiwan has grown. According to the United States Trade Representative, Taiwan is currently our 10th largest goods trading partner with $65.3 billion in total (two way) goods traded during 2016. Goods exports totaled $26.0 billion, while goods imports totaled $39.3 billion. As for...

Patents and a New Patent Linkage System in Taiwan - Patent protection in Taiwan is becoming of everincreasing importance as the country’s economic influence grows worldwide. The April 2018 issue of Sterne Kessler’s Global Patent Prosecution Newsletter includes information on patents and patentability in Taiwan, as well as a proposed patent linkage system for pharmaceutical products. Please...